Biotech

All Articles

Sanofi flunks MS research, inflicting an additional strike to Denali contract

.Sanofi has actually ceased a phase 2 trial of Denali Therapeutics-partnered oditrasertib in several...

Turnstone lays off 60%, shocks C-suite to extend money

.Turnstone Biologics is actually lessening its headcount through 60% and also agitating its C-suite ...

Gilead quits on $15M MASH wager after weighing preclinical records

.In a year that has found a permission and a raft of readouts for metabolic dysfunction-associated s...

Texas biotech axes cancer cells pact, pins wishes on being overweight

.Alaunos Therapies is axing an arrangement with Precigen, surrendering licensing rights to a customi...

Capricor allotments even more records for DMD therapy after triggering BLA

.Capricor Therapies is taking a success tour for their period 2 Duchenne muscular dystrophy (DMD) tr...

FDA locations Kezar lupus trial in grip complying with 4 person deaths

.The FDA has placed Kezar Life Sciences' lupus trial on hold after the biotech flagged 4 deaths thro...

Phase 3 Academic Rock test strikes SMA goal, delivering stock up 200%

.A period 3 trial of Intellectual Stone's spinal muscular degeneration (SMA) prospect has actually h...

CAMP 4 is most up-to-date to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapeutics has defined think about a $67 thousand IPO, with inflammation-focuse...

Galecto buys leukemia medication, loses bone tissue cancer possession in pivot

.A year after the breakdown of an idiopathic lung fibrosis applicant sent Galecto on a seek salvatio...

Judo throws down $100M to knock senseless kidney health condition

.Taking the floor covering is Judo Bio, an up-and-coming biotech equipped along with $100 million to...